{"id":685693,"date":"2022-09-15T08:34:51","date_gmt":"2022-09-15T12:34:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/"},"modified":"2022-09-15T08:34:51","modified_gmt":"2022-09-15T12:34:51","slug":"surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/","title":{"rendered":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System"},"content":{"rendered":"

\nDr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world\u2019s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery
\n<\/h2>\n
\n

DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced further advancement in the commercialization of its HOLO Portal\u2122 surgical guidance system. The Company is pleased to report that Jaideep Chunduri, MD, a board certified orthopaedic and spinal surgeon at Beacon Orthopedics & Sports Medicine in Cincinnati, Ohio, performed his first case with the HOLO Portal surgical guidance system.<\/p>\n

HOLO Portal, the world\u2019s first surgical guidance system to incorporate AI and AR, represents the initial clinical application of Surgalign\u2019s HOLO\u2122 AI digital health platform. The system\u2019s AI processes intraoperative images to autonomously segment and label the anatomy and plan patient-specific pedicle screw trajectories that are approved by the surgeon. The HOLO Portal system uses AR to overlay the segmented AI reconstruction over the patient\u2019s actual anatomy, providing real-time 3D visualization throughout the surgical procedure. This AR display helps surgeons visualize trajectories and guide surgical instruments.<\/p>\n

\u201cThe fidelity of the holographic surgical display is quite amazing, and the AI planned screws were right where I wanted them. HOLO Portal is truly next-generation technology, and even better it is straightforward and intuitive to adopt into a surgical technique,\u201d stated Dr. Chunduri, who joined Beacon Orthopedics & Sports Medicine in 2003. \u201cArtificial intelligence and augmented reality promise to make surgery more efficient and safer, which is ultimately why I chose to integrate HOLO Portal into my practice.\u201d<\/p>\n

In January 2022, the Company received U.S. Food & Drug Administration (FDA) 510(k) clearance for use of the HOLO Portal surgical guidance system within lumbar spine procedures. The Company is currently expanding the system\u2019s limited market release and intends to further increase site locations throughout the year. As cases are performed and data is accumulated, the Company plans to integrate new applications on its platform with the goal to both advance the quality of care and improve outcomes for patients.<\/p>\n

\u201cCongratulations to Dr. Chunduri for completing his first surgical case with the SurgalignTM<\/sup> HOLO Portal system,\u201d said Terry Rich, President and CEO of Surgalign. \u201cThe performance to date of the HOLO Portal system and the surgeon excitement generated by the technology have validated our high expectations. We believe that our HOLO AI technology will transform patient outcomes, and we couldn\u2019t be prouder to partner with Dr. Chunduri.\u201d<\/p>\n

\n About Surgalign Holdings, Inc.<\/strong>
\n
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.<\/p>\n

\n Forward Looking Statement<\/strong>
\n
This press release contains forward-looking statements based on management\u2019s current expectations, estimates and projections about our products, company, and industry, our management’s beliefs, and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and other variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include statements regarding the features, capabilities and benefits of the HOLO Portal system. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in our public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign’s website at\u00a0www.surgalign.com<\/a>\u00a0or the SEC’s website at\u00a0www.sec.gov<\/a>.<\/p>\n\n\n\n\n\n
\n Investor and Media Contact:\u00a0<\/strong>\n <\/td>\n\n Surgalign Contact:<\/strong>\n <\/td>\n<\/tr>\n
Glenn Wiener\u00a0<\/td>\nKristine Simmons<\/td>\n<\/tr>\n
\n gwiener@gwcco.com<\/a>
\n
\n
\n <\/a>\n <\/td>\n		\n ksimmons@surgalign.com<\/a>
\n
\n
\n <\/a>\n <\/td>\n<\/tr>\n
+1 917 887 8434<\/td>\n+1 619 206 4648<\/td>\n<\/tr>\n<\/table>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world\u2019s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced further advancement in the commercialization of its HOLO Portal\u2122 surgical guidance system. The Company is pleased to report that Jaideep Chunduri, MD, a board certified orthopaedic and spinal surgeon at Beacon Orthopedics & Sports Medicine in Cincinnati, Ohio, performed his first case with the HOLO Portal surgical guidance system. HOLO Portal, the world\u2019s first surgical guidance system … <\/p>\n

Continue reading “Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-685693","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSurgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world\u2019s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced further advancement in the commercialization of its HOLO Portal\u2122 surgical guidance system. The Company is pleased to report that Jaideep Chunduri, MD, a board certified orthopaedic and spinal surgeon at Beacon Orthopedics & Sports Medicine in Cincinnati, Ohio, performed his first case with the HOLO Portal surgical guidance system. HOLO Portal, the world\u2019s first surgical guidance system … Continue reading "Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T12:34:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System\",\"datePublished\":\"2022-09-15T12:34:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/\"},\"wordCount\":742,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/\",\"name\":\"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=\",\"datePublished\":\"2022-09-15T12:34:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/","og_locale":"en_US","og_type":"article","og_title":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk","og_description":"Dr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world\u2019s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced further advancement in the commercialization of its HOLO Portal\u2122 surgical guidance system. The Company is pleased to report that Jaideep Chunduri, MD, a board certified orthopaedic and spinal surgeon at Beacon Orthopedics & Sports Medicine in Cincinnati, Ohio, performed his first case with the HOLO Portal surgical guidance system. HOLO Portal, the world\u2019s first surgical guidance system … Continue reading \"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-15T12:34:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System","datePublished":"2022-09-15T12:34:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/"},"wordCount":742,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/","name":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=","datePublished":"2022-09-15T12:34:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NzAwMSM1MTU0MDEwIzIwMTY2NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surgalign-announces-third-clinical-site-in-the-commercialization-of-its-holo-portal-surgical-guidance-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Surgalign Announces Third Clinical Site in the\u00a0Commercialization of its HOLO Portal\u2122 Surgical Guidance System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=685693"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685693\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=685693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=685693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=685693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}